SCHEMBL30429115

SCHEMBL30429115

CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ NPY1R P25929 1/20 0.64
▸ NPY2R P49146 1/20 0.64
▸ NPY4R P50391 1/20 0.64
▸ NPY5R Q15761 1/20 0.64
▸ GLP1R P43220 17/20 0.60
▸ NMBR P28336 1/20 0.59
▸ GRPR P30550 1/20 0.59
▸ CCKBR P32239 2/20 0.59
▸ GIPR P48546 6/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30816278 0.91 NPY2R (0.65) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL29679866 0.90 NPY1R (0.72) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL31182657 0.90 NPY1R (0.68) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL29811065 0.89 NPY2R (0.71) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL29679514 0.89 NPY1R (0.68) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL31182839 0.89 NPY1R (0.67) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906385 0.89 NPY2R (0.71) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL29949651 0.89 NPY1R (0.67) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906422 0.88 NPY1R (0.68) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL31105379 0.88 NPY1R (0.64) NPY1RNPY2RNPY4RNPY5RGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165951-A1 Engineering, production and characterization of plant produced Nucleocapsid and Spike structural proteins of SARS CoV 2 as vaccine candidates against COVID19 MAMEDOV TARLAN (TR) 2023-06-01 — — US disclosed
Send feedback